Raised $1.5B, led by Paradigm.
The company said the funding supports expand its U.S. manufacturing facilities and ramp up hiring as it builds a nationwide drone delivery network.
Raised this week · updated 9 November 2026
Seven days of fresh capital, and what comes next.
Every disclosed round of $5M or more in the last seven days. Open a company to see its momentum, its stated priorities and where you could help.
The company said the funding supports expand its U.S. manufacturing facilities and ramp up hiring as it builds a nationwide drone delivery network.
The company said the funding supports support advanced technologies, expansion of U.S. manufacturing capacity,development and production of next-generation spacecraft, Synchronicity deployment, and international growth.
The company said the funding supports support its expansion across multiple verticals, spanning commercial vehicles,energy storage systems, power generation, autonomy software, and defense applications, as well as the continued ramp-up of its medium-duty platform manufacturing capacity.
The announcement did not set out what the funding supports.
The company said the funding supports advance customer pilots, testing, and validation, early manufacturing, and the expansion of its modular platform into a broader family of vehicles built for regional freight needs.
The announcement did not set out what the funding supports.
The company said the funding supports transition from technology development to industrial production, bringing its platform to mass production in 2027 for EV charging, energy storage, and DC microgrids, and expanding into AI data centers.
The company said the funding supports build and operate a demonstration plant, complete the engineering design for a 75-barrel-per-day commercial plant, secure airline fuel contracts, and begin licensing its Ouro reactor technology.
The company said the funding supports support the development of customer-specific AI agents and the company's expansion in the United States.
The company said the funding supports expand operations and its development efforts.
The company said the funding supports expand its U.S. radar manufacturing capacity, complete two large-scale manufacturing facilities by 2028, strengthen its domestic supply chain, and field additional sensing infrastructure for U.S.and Allied government customers.
The company said the funding supports support entry into the clinic and the generation of clinical data for its two lead TCR-CD3 bispecific programmes in oncology and autoimmune diseases.
The announcement did not set out what the funding supports.
The company said the funding supports accelerate delivery of OcientAIQ Solutions for organizations deploying agentic AI analytics against dynamic, petabyte-scale data.
The company said the funding supports advance its lead programme, ATX-011, through completion of Phase 1/2a studies in essential thrombocythaemia (ET) up to Phase 3 readiness, while also progressing additional MPN programmes toward IND submission.
The company said the funding supports expand its AI product suite, move into new markets, and double the team's headcount in 2027.
The company said the funding supports advance ANA-1, a small molecule therapeutic candidate for calcium pyrophosphate deposition disease (CPPD), through IND-enabling studies and into Phase 1.
The company said the funding supports support its transition to industrial scale, build demonstrator facilities for its reagents and lithium-ion battery electrolyte salts, expand the team, validate products with customers, and broaden commercial partnerships.
The company said the funding supports expand operations and its development efforts.
The company said the funding supports accelerate the global growth of its platform across merchants, AI agents, marketplaces, social networks, and shoppable advertising solutions.
The company said the funding supports further develop its threat detection technology and accelerate its commercial expansion across North America, targeting sectors such as financial services, government, and energy.
The company said the funding supports expand operations and its development efforts.
The company said the funding supports build its first automated 6MW production line, scale commercial-volume production of its perovskite modules, expand hardware integration with device makers, and accelerate global market deployment.
The company said the funding supports accelerate its tech manufacturing pipelines, expand its modular laboratory Pod production capacity, and support the launch and execution of its three upcoming orbital research missions scheduled for 2027.
The company said the funding supports accelerate its expansion across North American manufacturing and defense industrial markets.
The company said the funding supports expand its platform and operations.
The announcement did not set out what the funding supports.
The company said the funding supports scale its inference infrastructure, grow its team, and advance its generative media technology through research and new development initiatives throughout 2027.
The company said the funding supports launch new products, expand enterprise and international reach, scale into new revenue roles, and hire across engineering, research, product, design, and GTM teams.
The company said the funding supports expand compute capacity, grow the team, and accelerate deployment in the enterprise.
The announcement did not set out what the funding supports.
The company said the funding supports accelerate its agentic data security solutions, broaden visibility into agents, copilots, and models, enforce continuous least privilege access, expand its go-to-market execution, scale field and channel programs, and enter new geographies.
The company said the funding supports extend AI across the software development lifecycle (SDLC) by making production systems more resilient, and to hire across research, engineering, and go-to-market.
The company said the funding supports expand in the United States and Canada, prepare for entry into further international markets, and accelerate its AI roadmap as businesses connect AI agents directly to their financial infrastructure.
The company said the funding supports consolidate its position as an independent TV operating system, expand its global OEM partnerships, and invest further in product innovation and advertising technology.
The company said the funding supports expand strategic partnerships, invest in R&D and bring new products to market.
The announcement did not set out what the funding supports.
The company said the funding supports expand its portfolio of human cell types, increase market availability, and support wider customer access.
The company said the funding supports advance preparations for Phase 1 clinical testing of its BIONDD® technology, supporting key milestones including non-clinical GLP studies and the establishment of a manufacturing GMP process.
The company said the funding supports grow its team across client success, product, marketing, sales, and engineering,and to expand its product platform to enable AI agents to solve more problems for clients.
The company said the funding supports expand its engineering team, accelerate product development, and support customer growth.
The company said the funding supports support its next phase of growth, including team expansion, technology development, governance, and operating foundations.
The company said the funding supports expand the workflows its AI agents can manage and accelerate go-to-market efforts.
The company said the funding supports support its commercial expansion and upcoming product launch initiatives.
The company said the funding supports support its next phase of growth, including further international expansion,recruitment of wealth advisers, select strategic acquisitions, and strengthening its platform, processes, and service quality.
The company said the funding supports support its frontier robot foundation model training, as well as the manufacturing and deployment of its robot workers, Sonny and Cassie.
The company said the funding supports scale its infrastructure for continual machine learning, fund ongoing research and development for its optimization algorithms, expand its deep-tech engineering workforce, and accelerate the commercial rollout of its enterprise model alignment platform.
The company said the funding supports support continued development of its flagship AUV platform, buildout of its research and development facility, and further enhance recruitment for its undersea engineering team.
The company said the funding supports accelerate product development and expand its teams.
The company said the funding supports support the development of NTX-2001 in cocaine use disorder (CUD) through a Phase 1 drug-drug interaction study and a subsequent Phase 2 efficacy study.
The company said the funding supports accelerate its product development pipeline, expand its engineering team, and scale its enterprise features.
The company said the funding supports support continued model and product development and kick-start its go-to-market team serving enterprises and business process outsourcers.
The company said the funding supports expand into the US and Europe and grow the AI capabilities behind its platform.
The company said the funding supports expand into the US and Asia-Pacific, including New York and Singapore, grow its execution services for institutional clients, and pursue regulatory licensing in the US and other entry markets.
The company said the funding supports scale manufacturing capacity, and expand its physical AI capabilities into new commercial applications.
The company said the funding supports expand its senior team across product, engineering, and sales, bring its autonomous AI employees (Clerks) to more firms and types of engagements, help CPA firms extend their audit services into government programs, and build toward fully autonomous audit employees and continuous monitoring.
The company said the funding supports expand its research and engineering capabilities, accelerate development of its quantum processor architecture, and advance its first industrial deployment projects.
The company said the funding supports expand its core platform capabilities, accelerate strategic hiring, extend enterprise software integrations, and establish commercial distribution relationships with franchise brands and private equity platforms within the home services sector.
The company said the funding supports support of its surgeon faculty, and advance its biomimetic fixation platform technology.
The company said the funding supports industrialize the production of its first products, expand its team, train AI models, and run civil and military demonstrations worldwide.
The company said the funding supports support the commercial rollout of vitro.alive, its benchtop platform, and validation of vitro.scale, its higher-throughput platform.
The company said the funding supports accelerate the development of its agentic AI software platform and finance the acquisition of traditional insurance brokerages to deploy its automated workflows across acquired asset portfolios.
The company said the funding supports grow its internal product and engineering teams, scale up enterprise customer acquisition, and expand the technical features of its real-time collaborative business case platform to help sales organizations implement value selling motions.
Clear the filter, or open the full record.
Keep exploring